Heron Therapeutics announces a significant asset sale to CorMedix, reshaping its future and impacting the pharmaceutical preparations industry.
| Name | HERON THERAPEUTICS, INC. /DE/ |
|---|---|
| CIK | 0000818033 |
| Tickers | HRTX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 942875566 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 8582514400 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Heron Therapeutics announces a significant asset sale to CorMedix, reshaping its future and impacting the pharmaceutical preparations industry.
Heron Therapeutics, Inc. announces Q3 results, showcasing advancements in its product pipeline and ongoing commitment to pain management therapies.
Heron Therapeutics announces an asset purchase agreement with CorMedix, signaling a strategic shift and potential industry consolidation.
Heron Therapeutics reveals its financial results for Q3 2026, indicating growth potential and a focus on advancing pharmaceutical products.
Heron Therapeutics announces a new material definitive agreement, impacting its operations and the pharmaceutical preparations industry.
Heron Therapeutics registers an additional 26.56 million shares for employee equity plans, aiming to enhance retention and compensation.
1528 filing rows loaded from submissions recent; extra archives: CIK0000818033-submissions-001.json (527 filings, 1994-02-01 to 2011-06-29).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | DFAN14A | SOLICITING MATERIAL PURSUANT TO 240.14A-12 | 0001213900-26-120019 | 001-33221 | 261554908 | 34 | 126227 | |||
| 2026-11-10 | 4 | 4 | 0001193125-26-454742 | 8532 | ||||||
| 2026-11-09 | DEFA14A | DEFA14A | 0001193125-26-453822 | 001-33221 | 261536922 | 34 | 663131 | |||
| 2026-11-09 | 10-Q | 10-Q | 0001193125-26-452759 | 001-33221 | 261534038 | 34 | 10783949 | 1 | 1 | |
| 2026-11-09 | DEFA14A | DEFA14A | 0001193125-26-452725 | 001-33221 | 261533961 | 34 | 2466232 | |||
| 2026-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-452721 | 001-33221 | 261533945 | 34 | 514082 | 1 | 1 |
| 2026-11-09 | 8-K | 8-K | 1.01,3.03,7.01,9.01 | 0001193125-26-452672 | 001-33221 | 261533837 | 34 | 2954495 | 1 | 1 |
| 2026-11-03 | 4 | 4 | 0001193125-26-444851 | 13654 | ||||||
| 2026-11-03 | 4 | 4 | 0001193125-26-444847 | 13477 | ||||||
| 2026-11-03 | 4 | 4 | 0001193125-26-444842 | 13525 | ||||||
| 2026-11-03 | 4 | 4 | 0001193125-26-444831 | 8622 | ||||||
| 2026-10-27 | S-8 | S-8 | 0001193125-26-434429 | 333-299658 | 261491390 | 33 | 631015 | 1 | 1 | |
| 2026-10-21 | 4 | 4 | 0001193125-26-427545 | 8448 | ||||||
| 2026-10-21 | 4 | 4 | 0001193125-26-427542 | 8496 | ||||||
| 2026-10-21 | 4 | 4 | 0001193125-26-427524 | 8546 | ||||||
| 2026-09-29 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-407728 | 001-33221 | 261424640 | 34 | 198990 | 1 | 1 |
| 2026-08-14 | 8-K | 8-K | 1.01,3.03,9.01 | 0001193125-26-352403 | 001-33221 | 261282509 | 34 | 231381 | 1 | 1 |
| 2026-08-10 | 4 | 4 | 0001193125-26-341528 | 8532 | ||||||
| 2026-08-10 | 10-Q | 10-Q | 0001193125-26-341301 | 001-33221 | 261256299 | 34 | 10756010 | 1 | 1 | |
| 2026-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-341300 | 001-33221 | 261256292 | 34 | 582349 | 1 | 1 |
| 2026-08-03 | 4 | 4 | 0001193125-26-329848 | 7262 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-329804 | 13525 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-329720 | 13477 | ||||||
| 2026-08-03 | 4 | 4 | 0001193125-26-329694 | 10919 | ||||||
| 2026-07-20 | 4 | 4 | 0001193125-26-308958 | 7179 | ||||||
| 2026-07-20 | 4 | 4 | 0001193125-26-308922 | 8496 | ||||||
| 2026-07-20 | 4 | 4 | 0001193125-26-308887 | 8448 | ||||||
| 2026-06-25 | 8-K | 8-K | 3.01,9.01 | 0001193125-26-282988 | 001-33221 | 261122836 | 34 | 204678 | 1 | 1 |
| 2026-06-17 | 4 | 4 | 0001193125-26-273552 | 8526 | ||||||
| 2026-06-16 | 8-K | 8-K | 5.07 | 0001193125-26-272388 | 001-33221 | 261094170 | 34 | 265766 | 1 | 1 |
| 2026-06-08 | 4 | 4 | 0001193125-26-260931 | 7214 | ||||||
| 2026-06-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-253851 | 001-33221 | 261057688 | 34 | 216854 | 1 | 1 |
| 2026-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002913 | 005-39444 | 26971197 | 34 | 12066 | |||
| 2026-05-11 | 10-Q | 10-Q | 0001193125-26-215755 | 001-33221 | 26960931 | 34 | 8433482 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-215752 | 001-33221 | 26960922 | 34 | 509767 | 1 | 1 |
| 2026-05-07 | 4 | 4 | 0001193125-26-211230 | 7177 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-203374 | 7263 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-203344 | 10806 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-203272 | 10944 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-203196 | 11039 | ||||||
| 2026-04-30 | ARS | ARS | 0001193125-26-196314 | 001-33221 | 26923238 | 34 | 923325 | |||
| 2026-04-30 | DEFA14A | DEFA14A | 0001193125-26-196311 | 001-33221 | 26923235 | 34 | 580562 | |||
| 2026-04-30 | DEF 14A | DEF 14A | 0001193125-26-196306 | 001-33221 | 26923216 | 34 | 4257394 | 1 | 1 | |
| 2026-04-21 | 4 | 4 | 0001193125-26-165591 | 7138 | ||||||
| 2026-04-21 | 4 | 4 | 0001193125-26-165365 | 7181 | ||||||
| 2026-04-21 | 4 | 4 | 0001193125-26-165304 | 7282 | ||||||
| 2026-04-20 | PRE 14A | PRE 14A | 0001193125-26-164270 | 001-33221 | 26876015 | 34 | 5707964 | 1 | 1 | |
| 2026-04-06 | 4 | 4 | 0001193125-26-144196 | 7455 | ||||||
| 2026-04-06 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-142947 | 001-33221 | 26839644 | 34 | 864388 | 1 | 1 |
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001421 | 005-39444 | 26801464 | 34 | 7373 | |||
| 2026-02-26 | 10-K | 10-K | 0001193125-26-073515 | 001-33221 | 26681789 | 34 | 16571126 | 1 | 1 | |
| 2026-02-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-073502 | 001-33221 | 26681764 | 34 | 542969 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001600136-26-000002 | 005-39444 | 26639861 | 34 | 14101 | |||
| 2026-02-03 | 4 | 4 | 0001193125-26-034633 | 8555 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034632 | 25957 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034631 | 25951 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034630 | 8460 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034629 | 26011 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034628 | 4806 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034627 | 8508 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034626 | 25948 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034625 | 8503 | ||||||
| 2026-02-03 | 4 | OWNERSHIP DOCUMENT | 0000921895-26-000200 | 6456 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034492 | 6946 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034491 | 7001 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-034490 | 7041 | ||||||
| 2026-01-30 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000207 | 005-39444 | 26582382 | 34 | 7173 | |||
| 2026-01-20 | 4 | 4 | 0001193125-26-016451 | 7001 | ||||||
| 2026-01-20 | 4 | 4 | 0001193125-26-016423 | 6946 | ||||||
| 2026-01-20 | 4 | 4 | 0001193125-26-016413 | 7045 | ||||||
| 2026-01-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-008631 | 001-33221 | 26522185 | 34 | 238029 | 1 | 1 |
| 2025-11-26 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001600136-25-000011 | 005-39444 | 251525493 | 34 | 13955 | |||
| 2025-11-12 | 4 | 4 | 0001193125-25-276244 | 7128 | ||||||
| 2025-11-07 | 3 | 3 | 0001193125-25-271244 | 26387 | ||||||
| 2025-11-04 | 4 | 4 | 0001193125-25-264044 | 7002 | ||||||
| 2025-11-04 | 4 | 4 | 0001193125-25-264039 | 6947 | ||||||
| 2025-11-04 | 4 | 4 | 0001193125-25-264032 | 7042 | ||||||
| 2025-11-04 | 10-Q | 10-Q | 0001193125-25-263618 | 001-33221 | 251446510 | 34 | 10419869 | 1 | 1 | |
| 2025-11-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-263617 | 001-33221 | 251446501 | 34 | 603289 | 1 | 1 |
| 2025-10-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-25-000136 | 005-39444 | 251434778 | 34 | 6478 | |||
| 2025-10-29 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-25-256300 | 001-33221 | 251429955 | 34 | 213220 | 1 | 1 |
| 2025-10-21 | 4 | 4 | 0001193125-25-244582 | 27443 | ||||||
| 2025-10-21 | 4 | 4 | 0001193125-25-244560 | 27388 | ||||||
| 2025-10-21 | 4 | 4 | 0001193125-25-244520 | 27490 | ||||||
| 2025-10-17 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-25-004460 | 005-39444 | 251401744 | 34 | 11101 | |||
| 2025-10-17 | 4 | xslF345X05/ownership.xml | 0000902664-25-004459 | 12746 | ||||||
| 2025-10-15 | 8-K | 8-K | 5.07,9.01 | 0001193125-25-240253 | 001-33221 | 251394921 | 34 | 213331 | 1 | 1 |
| 2025-09-19 | DEF 14A | DEF 14A | 0001193125-25-209064 | 001-33221 | 251326836 | 34 | 1242281 | |||
| 2025-09-16 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002980 | 333-290143 | 251318722 | 33 | 1955 | ||
| 2025-09-16 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002979 | 333-290142 | 251318721 | 33 | 1955 | ||
| 2025-09-12 | CORRESP | filename1.htm | 0000950170-25-114551 | 20368 | ||||||
| 2025-09-12 | CORRESP | filename1.htm | 0000950170-25-114548 | 20676 | ||||||
| 2025-09-11 | UPLOAD | filename1.pdf | 0000000000-25-009896 | 333-290142 | 40346 | |||||
| 2025-09-11 | UPLOAD | filename1.pdf | 0000000000-25-009895 | 333-290143 | 40349 | |||||
| 2025-09-09 | S-3 | S-3 | 0000950170-25-113834 | 333-290143 | 251304035 | 33 | 1475644 | 1 | 1 | |
| 2025-09-09 | S-3 | S-3 | 0000950170-25-113830 | 333-290142 | 251303995 | 33 | 1573629 | 1 | 1 | |
| 2025-09-09 | PRE 14A | PRE 14A | 0000950170-25-113827 | 001-33221 | 251303958 | 34 | 377169 | |||
| 2025-08-28 | 8-K | 8-K | 1.01,9.01 | 0000950170-25-112048 | 001-33221 | 251274494 | 34 | 198766 | 1 | 1 |
| 2025-08-15 | 8-A12B | 8-A12B | 0000950170-25-109236 | 001-33221 | 251222441 | 34 | 67533 | |||
| 2025-08-15 | 8-K | 8-K | 1.01,3.03,5.03,8.01,9.01 | 0000950170-25-109234 | 001-33221 | 251222434 | 34 | 991249 | 1 | 1 |
| 2025-08-12 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000902664-25-003536 | 005-39444 | 251208296 | 34 | 856929 | |||
| 2025-08-12 | 4 | xslF345X05/ownership.xml | 0000902664-25-003535 | 14301 | ||||||
| 2025-08-12 | 4 | OWNERSHIP DOCUMENT | 0000921895-25-002160 | 10746 | ||||||
| 2025-08-12 | 8-K | 8-K | 1.01,5.03,8.01,9.01 | 0000950170-25-107416 | 001-33221 | 251207487 | 34 | 3525515 | 1 | 1 |
| 2025-08-12 | 8-K | 8-K | 1.01 | 0000950170-25-107404 | 001-33221 | 251207334 | 34 | 192031 | 1 | 1 |
| 2025-08-08 | 10-Q | 10-Q | 0000950170-25-105475 | 001-33221 | 251196219 | 34 | 9934990 | 1 | 1 | |
| 2025-08-08 | 8-K | 8-K | 1.01,2.02,2.03,3.02,8.01,9.01 | 0000950170-25-105474 | 001-33221 | 251196218 | 34 | 695778 | 1 | 1 |
| 2025-08-04 | 4 | 4 | 0000950170-25-102161 | 7002 | ||||||
| 2025-08-04 | 4 | 4 | 0000950170-25-102158 | 7393 | ||||||
| 2025-08-04 | 4 | 4 | 0000950170-25-102150 | 7042 | ||||||
| 2025-07-22 | 4 | 4 | 0000950170-25-097503 | 7002 | ||||||
| 2025-07-22 | 4 | 4 | 0000950170-25-097498 | 6947 | ||||||
| 2025-07-22 | 4 | 4 | 0000950170-25-097488 | 7046 | ||||||
| 2025-06-18 | 8-K | 8-K | 5.07 | 0000950170-25-087555 | 001-33221 | 251054598 | 34 | 240406 | 1 | 1 |
| 2025-06-17 | 4 | 4 | 0000950170-25-087534 | 7025 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-084006 | 7080 | ||||||
| 2025-05-07 | 4 | 4 | 0000950170-25-065310 | 5477 | ||||||
| 2025-05-06 | S-8 | S-8 | 0000950170-25-064589 | 333-287008 | 25918145 | 33 | 500554 | 1 | 1 | |
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-063971 | 001-33221 | 25915280 | 34 | 7896236 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-063973 | 001-33221 | 25915276 | 34 | 466902 | 1 | 1 |
| 2025-05-06 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-063967 | 001-33221 | 25915241 | 34 | 223859 | 1 | 1 |
| 2025-05-02 | 4 | 4 | 0000950170-25-063065 | 7001 | ||||||
| 2025-05-02 | 4 | 4 | 0000950170-25-063063 | 6946 | ||||||
| 2025-05-02 | 4 | 4 | 0000950170-25-063061 | 7041 | ||||||
| 2025-04-30 | DEFA14A | DEFA14A | 0000950170-25-060884 | 001-33221 | 25893582 | 34 | 1218278 | |||
| 2025-04-30 | ARS | ARS | 0000950170-25-060883 | 001-33221 | 25893577 | 34 | 743166 | |||
| 2025-04-30 | DEF 14A | DEF 14A | 0000950170-25-060882 | 001-33221 | 25893570 | 34 | 4847132 | 1 | 1 | |
| 2025-04-29 | 4 | 4 | 0000950170-25-059775 | 6428 | ||||||
| 2025-04-29 | 3 | 3 | 0000950170-25-059774 | 26260 | ||||||
| 2025-04-29 | 8-K | 8-K | 5.02,9.01 | 0000950170-25-059479 | 001-33221 | 25882131 | 34 | 235243 | 1 | 1 |
| 2025-04-22 | 4 | 4 | 0000950170-25-056495 | 7001 | ||||||
| 2025-04-22 | 4 | 4 | 0000950170-25-056492 | 6946 | ||||||
| 2025-04-22 | 4 | 4 | 0000950170-25-056488 | 7045 | ||||||
| 2025-04-03 | 4 | 4 | 0000950170-25-050677 | 7120 | ||||||
| 2025-02-27 | 10-K | 10-K | 0000950170-25-028374 | 001-33221 | 25673074 | 34 | 14260633 | 1 | 1 | |
| 2025-02-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-028372 | 001-33221 | 25673072 | 34 | 483555 | 1 | 1 |
| 2025-02-20 | 8-K | 8-K | 1.01,9.01 | 0000950170-25-023958 | 001-33221 | 25644543 | 34 | 286103 | 1 | 1 |
| 2025-02-04 | 4/A | 4/A | 0000950170-25-013789 | 7102 | ||||||
| 2025-02-04 | 4/A | 4/A | 0000950170-25-013780 | 8539 | ||||||
| 2025-02-04 | 4/A | 4/A | 0000950170-25-013770 | 7117 | ||||||
| 2025-02-04 | 4/A | 4/A | 0000950170-25-013756 | 7121 | ||||||
| 2025-02-04 | 4/A | 4/A | 0000950170-25-013741 | 7131 | ||||||
| 2025-02-04 | 4/A | 4/A | 0000950170-25-013728 | 7132 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013045 | 7656 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013044 | 7608 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013042 | 7706 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012119 | 7027 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012107 | 22348 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012101 | 22340 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012096 | 22354 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012094 | 22355 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012043 | 23754 | ||||||
| 2025-01-22 | 4 | 4 | 0000950170-25-007557 | 7160 | ||||||
| 2025-01-22 | 4 | 4 | 0000950170-25-007549 | 7008 | ||||||
| 2025-01-22 | 4 | 4 | 0000950170-25-007545 | 7259 | ||||||
| 2024-12-23 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-139569 | 001-33221 | 241573586 | 34 | 224058 | 1 | 1 |
| 2024-12-03 | 8-K | 8-K | 8.01 | 0000950170-24-132874 | 001-33221 | 241523697 | 34 | 171087 | 1 | 1 |
| 2024-11-12 | SC 13G | HERON THERAPEUTICS, INC. | 0000902664-24-006401 | 005-39444 | 241444204 | 34 | 75719 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-124698 | 001-33221 | 241443892 | 34 | 7171685 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-124626 | 001-33221 | 241443561 | 34 | 367855 | 1 | 1 |
| 2024-11-08 | SC 13G | us4277461020_110824.txt | 0002012383-24-003510 | 005-39444 | 241439646 | 34 | 13872 | |||
| 2024-11-06 | 4 | 4 | 0000950170-24-122084 | 7150 | ||||||
| 2024-11-05 | 3 | 3 | 0000950170-24-121242 | 14346 | ||||||
| 2024-11-04 | 8-K | 8-K | 5.02,7.01 | 0000950170-24-120902 | 001-33221 | 241424633 | 34 | 197176 | 1 | 1 |
| 2024-10-24 | SC 13G | us4277461020_102424.txt | 0002012383-24-002188 | 005-39444 | 241392059 | 34 | 13860 | |||
| 2024-10-21 | 4 | 4 | 0000950170-24-115927 | 6967 | ||||||
| 2024-10-21 | 4 | 4 | 0000950170-24-115925 | 7015 | ||||||
| 2024-10-21 | 4 | 4 | 0000950170-24-115920 | 7065 | ||||||
| 2024-08-06 | S-8 | S-8 | 0000950170-24-091916 | 333-281293 | 241179945 | 33 | 706943 | 1 | 1 | |
| 2024-08-06 | 10-Q | 10-Q | 0000950170-24-091764 | 001-33221 | 241179108 | 34 | 6779919 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-091769 | 001-33221 | 241179097 | 34 | 357230 | 1 | 1 |
| 2024-07-22 | 4 | 4 | 0000950170-24-085096 | 7065 | ||||||
| 2024-07-22 | 4 | 4 | 0000950170-24-085092 | 7014 | ||||||
| 2024-07-22 | 4 | 4 | 0000950170-24-085089 | 6967 | ||||||
| 2024-07-02 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-080026 | 001-33221 | 241093007 | 34 | 196261 | 1 | 1 |
| 2024-06-18 | 8-K | 8-K | 5.02,5.03,5.07,9.01 | 0000950170-24-074952 | 001-33221 | 241052487 | 34 | 265172 | 1 | 1 |
| 2024-06-17 | 4 | 4 | 0000950170-24-074168 | 7045 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070250 | 7092 | ||||||
| 2024-05-31 | SC 13D/A | AMENDMENT NO. 3 TO THE SCHEDULE 13D | 0000921895-24-001343 | 005-39444 | 241008289 | 34 | 67364 | |||
| 2024-05-29 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-065636 | 001-33221 | 24994067 | 34 | 197289 | 1 | 1 |
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-053964 | 001-33221 | 24919713 | 34 | 6330307 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-053963 | 001-33221 | 24919710 | 34 | 350756 | 1 | 1 |
| 2024-04-29 | ARS | ARS | 0001140361-24-022885 | 001-33221 | 24889667 | 34 | 627687 | |||
| 2024-04-29 | DEF 14A | DEF 14A | 0001140361-24-022881 | 001-33221 | 24889644 | 34 | 2970390 | |||
| 2024-04-19 | 4 | 4 | 0000950170-24-046134 | 21788 | ||||||
| 2024-04-19 | PRE 14A | PRE 14A | 0001140361-24-020831 | 001-33221 | 24858959 | 34 | 2987683 | |||
| 2024-04-19 | 4 | 4 | 0000950170-24-046085 | 20484 | ||||||
| 2024-04-19 | 4 | 4 | 0000950170-24-046050 | 7064 | ||||||
| 2024-04-05 | 4 | 4 | 0000950170-24-042226 | 20602 | ||||||
| 2024-03-21 | 8-K | 8-K | 5.02 | 0001193125-24-073897 | 001-33221 | 24771861 | 34 | 145934 | 1 | 1 |
| 2024-03-12 | 10-K | 10-K | 0000950170-24-029951 | 001-33221 | 24742255 | 34 | 10567119 | 1 | 1 | |
| 2024-03-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-029926 | 001-33221 | 24742150 | 34 | 409301 | 1 | 1 |
| 2024-02-14 | SC 13G/A | greatpoint-hrtx123123a1.htm | 0001172661-24-001524 | 005-39444 | 24639393 | 34 | 110524 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023728 | 005-39444 | 24638761 | 34 | 90759 | |||
| 2024-02-14 | SC 13G/A | deeptrack-hrtx123123a1.htm | 0001172661-24-000924 | 005-39444 | 24632655 | 34 | 103088 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021114 | 005-39444 | 24628542 | 34 | 13259 | |||
| 2024-02-06 | SC 13G/A | hero23a13.htm | 0000038777-24-000015 | 005-39444 | 24599008 | 34 | 174062 | |||
| 2024-01-24 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-013587 | 001-33221 | 24554280 | 34 | 168867 | 1 | 1 |
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001982 | 7352 | ||||||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001981 | 7351 | ||||||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001980 | 8718 | ||||||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001979 | 7342 | ||||||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001978 | 7337 | ||||||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001977 | 7964 | ||||||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001976 | 8047 | ||||||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001975 | 7999 | ||||||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001974 | 8104 | ||||||
| 2024-01-16 | 4 | FORM 4 SUBMISSION | 0001209191-24-001626 | 13163 | ||||||
| 2024-01-11 | 8-K | 8-K | 1.01,9.01 | 0001193125-24-006600 | 001-33221 | 24529325 | 34 | 169246 | 1 | 1 |
| 2023-12-22 | 8-K | 8-K | 8.01 | 0001193125-23-302150 | 001-33221 | 231510224 | 34 | 146330 | 1 | 1 |
| 2023-12-21 | 8-K | 8-K | 5.02 | 0001193125-23-301337 | 001-33221 | 231506327 | 34 | 143051 | 1 | 1 |
| 2023-12-07 | SC 13G/A | FILING HERON THERAPEUTICS, INC. | 0000019617-23-000588 | 005-39444 | 34 | 89985 | ||||
| 2023-12-06 | SC 13G/A | us4277461020_120623.txt | 0001306550-23-010470 | 005-39444 | 231470221 | 34 | 12611 | |||
| 2023-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-056198 | 4802 | ||||||
| 2023-11-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-055948 | 5124 | ||||||
| 2023-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-055664 | 5177 | ||||||
| 2023-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-055663 | 5081 | ||||||
| 2023-11-14 | 10-Q | 10-Q | 0000950170-23-063714 | 001-33221 | 231406433 | 34 | 7971076 | 1 | 1 | |
| 2023-11-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-063702 | 001-33221 | 231406184 | 34 | 462363 | 1 | 1 |
| 2023-10-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-053030 | 18904 | ||||||
| 2023-09-06 | 424B3 | 424B3 | 0001193125-23-228822 | 333-274167 | 231237628 | 33 | 196627 | |||
| 2023-08-31 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-08-31 16:00:00 | 9999999995-23-002550 | 333-274167 | 231230482 | 33 | 1913 | ||
| 2023-08-30 | CORRESP | filename1.htm | 0001193125-23-224255 | 6516 | ||||||
| 2023-08-28 | UPLOAD | filename1.pdf | 0000000000-23-009456 | 40532 | ||||||
| 2023-08-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-047180 | 5183 | ||||||
| 2023-08-23 | S-3 | S-3 | 0001193125-23-219106 | 333-274167 | 231197647 | 33 | 323938 | |||
| 2023-08-14 | 10-Q | 10-Q | 0000950170-23-042431 | 001-33221 | 231170460 | 34 | 9500750 | 1 | 1 | |
| 2023-08-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-042414 | 001-33221 | 231170191 | 34 | 506189 | 1 | 1 |
| 2023-08-01 | D | xslFormDX01/primary_doc.xml | 06b | 0001209191-23-043921 | 021-488462 | 231130952 | 33 | 12066 | ||
| 2023-07-25 | 4 | OWNERSHIP DOCUMENT | 0000921895-23-001721 | 9755 | ||||||
| 2023-07-25 | 3 | OWNERSHIP DOCUMENT | 0000921895-23-001720 | 6664 | ||||||
| 2023-07-25 | SC 13D/A | AMENDMENT NO. 2 TO THE SCHEDULE 13D | 0000921895-23-001719 | 005-39444 | 231108691 | 34 | 74311 | |||
| 2023-07-24 | 8-K | 8-K | 1.01,3.02,5.02,7.01,9.01 | 0001193125-23-191942 | 001-33221 | 231103881 | 34 | 680652 | 1 | 1 |
| 2023-07-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-042787 | 5562 | ||||||
| 2023-07-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-042480 | 13174 | ||||||
| 2023-07-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-042479 | 13082 | ||||||
| 2023-06-30 | S-8 | S-8 | 0001193125-23-180386 | 333-273059 | 231061744 | 33 | 276297 | |||
| 2023-06-23 | 3 | FORM 3 SUBMISSION | 0001209191-23-039402 | 9688 | ||||||
| 2023-06-23 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-029646 | 001-33221 | 231037937 | 34 | 298606 | 1 | 1 |
| 2023-06-12 | 3 | FORM 3 SUBMISSION | 0001209191-23-036343 | 10364 | ||||||
| 2023-06-12 | 8-K | 8-K | 5.02,5.03,5.07,9.01 | 0000950170-23-027374 | 001-33221 | 231007228 | 34 | 498656 | 1 | 1 |
| 2023-05-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-031910 | 5182 | ||||||
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021237 | 001-33221 | 23911116 | 34 | 7075822 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-021213 | 001-33221 | 23910951 | 34 | 437231 | 1 | 1 |
| 2023-05-01 | ARS | ARS | 0000950170-23-016047 | 001-33221 | 23870540 | 34 | 1564409 | |||
| 2023-05-01 | DEF 14A | DEF 14A | 0000950170-23-016042 | 001-33221 | 23870503 | 34 | 5487693 | |||
| 2023-04-20 | PRE 14A | PRE 14A | 0000950170-23-013675 | 001-33221 | 23833160 | 34 | 3090397 | |||
| 2023-04-20 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-013583 | 001-33221 | 23831569 | 34 | 375096 | 1 | 1 |
| 2023-04-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-024500 | 13173 | ||||||
| 2023-04-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-024499 | 13121 | ||||||
| 2023-04-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-024498 | 13082 | ||||||
| 2023-04-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-024497 | 13156 | ||||||
| 2023-04-13 | SC 13G | greatpoint-hrtx041323.htm | 0001172661-23-001684 | 005-39444 | 23817946 | 34 | 112891 | |||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023385 | 10905 | ||||||
| 2023-04-03 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-011487 | 001-33221 | 23790883 | 34 | 385100 | 1 | 1 |
| 2023-03-29 | 10-K | 10-K | 0000950170-23-010603 | 001-33221 | 23775317 | 34 | 12638733 | 1 | 1 | |
| 2023-03-23 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-009489 | 001-33221 | 23756304 | 34 | 496588 | 1 | 1 |
| 2023-03-13 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-007473 | 001-33221 | 23725924 | 34 | 302960 | 1 | 1 |
| 2023-03-06 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-006139 | 001-33221 | 23707760 | 34 | 390961 | 1 | 1 |
| 2023-03-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-014628 | 8431 | ||||||
| 2023-03-02 | 3 | FORM 3 SUBMISSION | 0001209191-23-014621 | 7804 | ||||||
| 2023-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-012924 | 11417 | ||||||
| 2023-02-22 | SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-23-000593 | 005-39444 | 23653494 | 34 | 378596 | |||
| 2023-02-22 | 8-K | 8-K | 1.01,5.02,7.01,9.01 | 0001193125-23-044236 | 001-33221 | 23650663 | 34 | 346904 | 1 | 1 |
| 2023-02-15 | SC 13G/A | arrowmark-hrtx123122a2.htm | 0001172661-23-001475 | 005-39444 | 23632208 | 34 | 54372 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 3 | 0001214659-23-002397 | 005-39444 | 23628411 | 34 | 77586 | |||
| 2023-02-13 | SC 13G/A | SC 13G/A | 0001193125-23-034205 | 005-39444 | 23614688 | 34 | 42010 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016123 | 005-39444 | 23603369 | 34 | 13178 | |||
| 2023-02-08 | 3 | OWNERSHIP DOCUMENT | 0000921895-23-000348 | 13925 | ||||||
| 2023-02-08 | 3 | OWNERSHIP DOCUMENT | 0000921895-23-000347 | 7215 | ||||||
| 2023-02-06 | SC 13D | SCHEDULE 13D | 0000921895-23-000284 | 005-39444 | 23588774 | 34 | 303133 | |||
| 2023-02-03 | SC 13G/A | us4277461020_020323.txt | 0001306550-23-007834 | 005-39444 | 23586368 | 34 | 13556 | |||
| 2023-01-31 | SC 13G/A | hero22a121.htm | 0000038777-23-000023 | 005-39444 | 23571459 | 34 | 209914 | |||
| 2023-01-23 | SC 13G/A | FILING HERON THERAPEUTICS, INC. | 0000019617-23-000134 | 005-39444 | 34 | 90002 | ||||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-004304 | 6195 | ||||||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-004303 | 5584 | ||||||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-004302 | 6143 | ||||||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-004301 | 6108 | ||||||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-004299 | 6181 | ||||||
| 2023-01-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-003564 | 14859 | ||||||
| 2023-01-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-003563 | 14849 | ||||||
| 2023-01-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-003562 | 13089 | ||||||
| 2023-01-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-003561 | 13051 | ||||||
| 2023-01-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-003560 | 14842 | ||||||
| 2023-01-10 | SC 13G/A | Heron_Therapeutics_Inc.txt | 0000093751-23-000001 | 005-39444 | 23519686 | 34 | 8645 | |||
| 2023-01-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-000458 | 001-33221 | 23516772 | 34 | 419516 | 1 | 1 |
| 2022-12-29 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-027082 | 001-33221 | 221496439 | 34 | 301709 | 1 | 1 |
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062192 | 7240 | ||||||
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062191 | 7239 | ||||||
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062188 | 7230 | ||||||
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062187 | 7225 | ||||||
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062184 | 7245 | ||||||
| 2022-11-08 | 10-Q | 10-Q | 0001564590-22-037047 | 001-33221 | 221369180 | 34 | 7994670 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-037038 | 001-33221 | 221368976 | 34 | 529194 | 1 | 1 |
| 2022-10-20 | 424B5 | 424B5 | 0001193125-22-265939 | 333-267781 | 221321309 | 33 | 195693 | |||
| 2022-10-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-10-18 16:00:00 | 9999999995-22-003077 | 333-267781 | 221317152 | 33 | 1913 | ||
| 2022-10-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-053836 | 13143 | ||||||
| 2022-10-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-053835 | 13131 | ||||||
| 2022-10-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-053834 | 13091 | ||||||
| 2022-10-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-053832 | 13051 | ||||||
| 2022-10-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-053827 | 13126 | ||||||
| 2022-10-13 | CORRESP | filename1.htm | 0001193125-22-262254 | 7168 | ||||||
| 2022-10-13 | UPLOAD | filename1.pdf | 0000000000-22-011246 | 40379 | ||||||
| 2022-10-07 | S-3 | S-3 | 0001193125-22-259613 | 333-267781 | 221300936 | 33 | 314653 | |||
| 2022-09-19 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-031836 | 001-33221 | 221249427 | 34 | 7844296 | 1 | 1 |
| 2022-09-09 | S-8 | S-8 | 0001193125-22-241942 | 333-267352 | 221236105 | 33 | 201058 | |||
| 2022-08-19 | SC 13G | deeptrack-hrtx08092022.htm | 0001172661-22-002028 | 005-39444 | 221180762 | 34 | 103269 | |||
| 2022-08-10 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-22-217430 | 001-33221 | 221152421 | 34 | 621223 | 1 | 1 |
| 2022-08-09 | 10-Q | 10-Q | 0001564590-22-028599 | 001-33221 | 221146630 | 34 | 8003170 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-028597 | 001-33221 | 221146528 | 34 | 553994 | 1 | 1 |
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-043292 | 5620 | ||||||
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-043291 | 5568 | ||||||
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-043289 | 5530 | ||||||
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-043288 | 5603 | ||||||
| 2022-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-042263 | 14858 | ||||||
| 2022-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-042262 | 14847 | ||||||
| 2022-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-042261 | 13091 | ||||||
| 2022-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-042260 | 13051 | ||||||
| 2022-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-042259 | 13126 | ||||||
| 2022-06-30 | 8-K | 8-K | 2.05,9.01 | 0001564590-22-024885 | 001-33221 | 221056608 | 34 | 232619 | 1 | 1 |
| 2022-06-14 | 8-K | 8-K | 7.01,9.01 | 0001564590-22-023137 | 001-33221 | 221013510 | 34 | 232364 | 1 | 1 |
| 2022-05-25 | 8-K | 8-K | 5.07 | 0001564590-22-021277 | 001-33221 | 22963328 | 34 | 216336 | 1 | 1 |
| 2022-05-09 | 10-Q | 10-Q | 0001564590-22-018877 | 001-33221 | 22905150 | 34 | 6654134 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-018871 | 001-33221 | 22905018 | 34 | 494395 | 1 | 1 |
| 2022-05-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-027232 | 7010 | ||||||
| 2022-04-25 | DEF 14A | DEF 14A | 0001564590-22-015345 | 001-33221 | 22847493 | 34 | 3694481 | |||
| 2022-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-024523 | 13141 | ||||||
| 2022-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-024522 | 13130 | ||||||
| 2022-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-024521 | 13090 | ||||||
| 2022-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-024520 | 13050 | ||||||
| 2022-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-024519 | 13124 | ||||||
| 2022-04-14 | PRE 14A | PRE 14A | 0001564590-22-014474 | 001-33221 | 22827666 | 34 | 3760247 | |||
| 2022-04-11 | SC 13G/A | Heron_Therapeutics_Inc.txt | 0000093751-22-000491 | 005-39444 | 22819331 | 34 | 10562 | |||
| 2022-03-25 | 8-K | 8-K | 7.01,9.01 | 0001564590-22-011751 | 001-33221 | 22768327 | 34 | 1916982 | 1 | 1 |
| 2022-03-17 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-010729 | 001-33221 | 22746906 | 34 | 219454 | 1 | 1 |
| 2022-02-28 | 10-K | 10-K | 0001564590-22-007618 | 001-33221 | 22689633 | 34 | 13043740 | 1 | 1 | |
| 2022-02-28 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-007608 | 001-33221 | 22689314 | 34 | 541277 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022825 | 005-39444 | 22632106 | 34 | 126885 | |||
| 2022-02-14 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-22-002555 | 005-39444 | 22631041 | 34 | 77561 | |||
| 2022-02-14 | SC 13G/A | arrowmark-hrtx123121a1.htm | 0001172661-22-000639 | 005-39444 | 22629429 | 34 | 54175 | |||
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-040411 | 005-39444 | 22627242 | 34 | 39159 | |||
| 2022-02-11 | SC 13G | HERON_THERAPEUTICS_INC.txt | 0000093751-22-000244 | 005-39444 | 22617243 | 34 | 10509 | |||
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-017739 | 005-39444 | 22609952 | 34 | 13173 | |||
| 2022-02-04 | SC 13G/A | SEC SCHEDULE 13G | 0001678858-22-000298 | 005-39444 | 22591489 | 34 | 33152 | |||
| 2022-02-03 | SC 13G/A | hero21a11.htm | 0000038777-22-000033 | 005-39444 | 22587908 | 34 | 212105 | |||
| 2022-02-01 | SC 13G/A | us4277461020_020122.txt | 0000834237-22-004531 | 005-39444 | 22579981 | 34 | 13586 | |||
| 2022-01-24 | SC 13G | FILING HERON THERAPEUTICS, INC. | 0000019617-22-000165 | 005-39444 | 34 | 90073 | ||||
| 2022-01-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-003364 | 13126 | ||||||
| 2022-01-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-003362 | 13117 | ||||||
| 2022-01-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-003361 | 13077 | ||||||
| 2022-01-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-003360 | 13037 | ||||||
| 2022-01-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-003358 | 13109 | ||||||
| 2021-12-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-071173 | 4929 | ||||||
| 2021-12-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-071172 | 9441 | ||||||
| 2021-12-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-071170 | 7239 | ||||||
| 2021-12-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-071169 | 9432 | ||||||
| 2021-12-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-071168 | 7225 | ||||||
| 2021-12-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-071167 | 7245 | ||||||
| 2021-12-09 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-059819 | 001-33221 | 211480314 | 34 | 203800 | 1 | 1 |
| 2021-11-18 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-057541 | 001-33221 | 211422614 | 34 | 189768 | 1 | 1 |
| 2021-11-03 | 10-Q | 10-Q | 0001564590-21-053953 | 001-33221 | 211375453 | 34 | 8010261 | 1 | 1 | |
| 2021-11-03 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-053940 | 001-33221 | 211375324 | 34 | 540310 | 1 | 1 |
| 2021-10-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-060553 | 14196 | ||||||
| 2021-10-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-060551 | 14187 | ||||||
| 2021-10-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-060550 | 14146 | ||||||
| 2021-10-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-060549 | 14107 | ||||||
| 2021-10-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-060547 | 14179 | ||||||
| 2021-10-04 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-049889 | 001-33221 | 211301137 | 34 | 199609 | 1 | 1 |
| 2021-09-29 | 3 | FORM 3 SUBMISSION | 0001209191-21-058056 | 7775 | ||||||
| 2021-09-29 | 3 | FORM 3 SUBMISSION | 0001209191-21-058054 | 7769 | ||||||
| 2021-09-24 | 8-K | 8-K | 5.02 | 0001564590-21-048772 | 001-33221 | 211274096 | 34 | 171122 | 1 | 1 |
| 2021-09-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-057420 | 5363 | ||||||
| 2021-09-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-057419 | 5361 | ||||||
| 2021-09-14 | S-8 | S-8 | 0001564590-21-047901 | 333-259518 | 211252738 | 33 | 283746 | |||
| 2021-08-30 | UPLOAD | filename1.pdf | 0000000000-21-010556 | 39769 | ||||||
| 2021-08-10 | CORRESP | filename1.htm | 0001564590-21-043096 | 57565 | ||||||
| 2021-08-09 | 10-Q | 10-Q | 0001564590-21-042362 | 001-33221 | 211154731 | 34 | 7684993 | 1 | 1 | |
| 2021-08-09 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-042359 | 001-33221 | 211154716 | 34 | 529342 | 1 | 1 |
| 2021-08-02 | 8-K | 8-K | 4.01,9.01 | 0001564590-21-039796 | 001-33221 | 211136425 | 34 | 171493 | 1 | 1 |
| 2021-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-046791 | 10765 | ||||||
| 2021-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-046790 | 10750 | ||||||
| 2021-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-046789 | 10715 | ||||||
| 2021-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-046788 | 10677 | ||||||
| 2021-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-046786 | 9032 | ||||||
| 2021-07-15 | UPLOAD | filename1.pdf | 0000000000-21-008767 | 47684 | ||||||
| 2021-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-042433 | 5211 | ||||||
| 2021-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-042429 | 5200 | ||||||
| 2021-06-17 | 8-K | 8-K | 5.07 | 0001564590-21-033349 | 001-33221 | 211024723 | 34 | 206353 | 1 | 1 |
| 2021-05-28 | S-3ASR | S-3ASR | 0001193125-21-176988 | 333-256620 | 21980475 | 33 | 258112 | |||
| 2021-05-25 | 8-K | 8-K | 1.01,2.03,3.02,9.01 | 0001564590-21-029621 | 001-33221 | 21958236 | 34 | 844727 | 1 | 1 |
| 2021-05-13 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-027241 | 001-33221 | 21917331 | 34 | 11162698 | 1 | 1 |
| 2021-05-10 | 10-Q | 10-Q | 0001564590-21-025796 | 001-33221 | 21905401 | 34 | 6902636 | 1 | 1 | |
| 2021-05-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-025793 | 001-33221 | 21905388 | 34 | 478806 | 1 | 1 |
| 2021-05-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-030014 | 7011 | ||||||
| 2021-04-22 | DEFA14A | DEFA14A | 0001564590-21-020111 | 001-33221 | 21844964 | 34 | 2124386 | |||
| 2021-04-22 | DEF 14A | DEF 14A | 0001564590-21-020104 | 001-33221 | 21844804 | 34 | 2559108 | |||
| 2021-04-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-027119 | 5211 | ||||||
| 2021-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-026845 | 9047 | ||||||
| 2021-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-026844 | 14406 | ||||||
| 2021-04-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-026843 | 8998 |
One latest value per concept from companyfacts (367 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 190.27M | 2026-11-04 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 235.10M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 155.00M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001193125-26-196306 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.74M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001193125-26-196306 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.54M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001193125-26-196306 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 119.92 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001193125-26-196306 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 6.14 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001193125-26-196306 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 739.43 | 2026-10-26 | S-8 | 2026-10-27 | 0001193125-26-434429 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 739.43 | 2026-10-26 | S-8 | 2026-10-27 | 0001193125-26-434429 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 8.50M | 2026-10-26 | S-8 | 2026-10-27 | 0001193125-26-434429 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-26 | S-8 | 2026-10-27 | 0001193125-26-434429 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 8.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AccountsPayableOtherCurrent | Accounts Payable, Other, Current | USD | 559,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-028374 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 86.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 403,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 6.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 2.62M | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-12 | 0001193125-14-194964 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 2.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | AccruedRentCurrent | Accrued Rent, Current | USD | 780,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 | |
| us-gaap | AccruedSalaries | Accrued Salaries (Deprecated 2009-01-31) | USD | 401,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 656,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | AccruedVacationCurrent | Accrued Vacation, Current | USD | 2.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 12.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -7,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.96B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | USD | 230,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010603 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 3.08M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 98,000 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 10.89M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 371,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 9.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 734,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 73,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 4.27M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124698 |
| us-gaap | Assets | Assets | USD | 230.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 209.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AssetsFairValueDisclosureRecurring | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) | USD | 49.22M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-23 | 0001193125-17-054088 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 4,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 7,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 11.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 67.36M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-158506 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 5,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 92,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 300.62M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 222.97M | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-05 | 0001564590-19-028537 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 11.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 11.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGains | Available-for-sale Securities, Gross Realized Gains | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedLosses | Available-for-sale Securities, Gross Realized Losses | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedGains | Available-for-sale Securities, Gross Unrealized Gain | USD | 7,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLoss | Available-for-sale Securities, Gross Unrealized Loss | USD | 10,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 |
| us-gaap | Cash | Cash | USD | 83.50M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001564590-22-028599 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 11.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 21.20M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-05 | 0001564590-19-028537 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 23.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 11.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -17.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 3.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/shares_unit | 4.35 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 220,164 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007841 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 61.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 1 | 2026-06-25 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-341301 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 400.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 188.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 188.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -18.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | USD | 15.60M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-451641 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 1.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ContractsRevenue | Contracts Revenue (Deprecated 2018-01-31) | USD | 0 | 2013-10-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 2.76M | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 34.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 64,000 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-07 | 0001193125-11-299888 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 149.81M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-08 | 0000950170-25-105475 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 31.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 4.59M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 84.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 1.57M | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 | |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 369,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 4.67M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-451641 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.1 | 2023-08-15 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 78,000 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001193125-14-400994 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | -9,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 2.76M | 2017-12-31 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001193125-18-320941 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 35,000 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-26 | 0001193125-12-132146 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 415.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-19 | 0001193125-16-469890 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 329.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 35.10M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 34.10M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 6.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 19.20M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 400,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 57.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 3.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 415.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 134,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 0 | 2013-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-19 | 0001193125-16-469890 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.03 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | Depreciation | Depreciation | USD | 1.50M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 741,000 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001193125-17-252860 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | DepreciationExpense | Depreciation Expense (Deprecated 2009-01-31) | USD | 197,000 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationRevenue | Disposal Group, Including Discontinued Operation, Revenue | USD | 0 | 2012-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.63 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0001564590-22-018877 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.081 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.283 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 8.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 22.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwards | Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards (Deprecated 2011-01-31) | USD | 21.10M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsOnNonvestedAwardsWeightedAveragePeriodOfRecognition | Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards, Weighted Average Period of Recognition (Deprecated 2011-01-31) | pure | 2.9 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | EquityIssuancePerShareAmount | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | USD | 0.525 | 2012-07-01 | 2012-07-30 | 2012 | Q2 | 10-Q | 2012-08-09 | 0001193125-12-346661 |
| us-gaap | FixturesAndEquipmentGross | Fixtures and Equipment, Gross | USD | 4.04M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 4,000 | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-26 | 0001193125-12-132146 |
| us-gaap | GainLossOnDispositionOfProperty | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) | USD | 4,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | GainLossOnSaleOfInterestInProjects | Gain (Loss) on Sale of Interest in Projects | USD | 2.50M | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-341301 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -11.34M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 35.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | GrossProfit | Gross Profit | USD | 76.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | GuaranteedBenefitsIncurred | Guaranteed Benefits Incurred (Deprecated 2013-01-31) | USD | 944,000 | 2000-07-01 | 2007-06-30 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | -51.31M | 2018-10-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -4.83M | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-10 | 0001193125-12-224867 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -2.87 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091072 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | 1.09M | 2012-10-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | USD | 1.08M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091072 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share | USD/shares | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -1.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 74.36M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -4.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 5.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 210,000 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 146,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-028374 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -619,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -2.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -2.01M | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-12 | 0001193125-14-194964 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 1.66M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 4.46M | 2017-01-01 | 2017-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001193125-18-320941 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -434,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 1.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 3.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 77,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 298,000 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-341301 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 9.82M | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-341301 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 29.70M | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-341301 |
| us-gaap | InterestExpense | Interest Expense | USD | 3.87M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-029951 |
| us-gaap | InterestExpenseDebtExcludingAmortization | Interest Expense, Debt, Excluding Amortization | USD | 200,000 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001193125-17-252860 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 9.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | -293,000 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-08 | 0001193125-16-675250 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | -2.33M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-06 | 0001193125-17-333663 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 2.29M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-06 | 0001193125-17-333663 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 7.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 904,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 160,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 14.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 91.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 57.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 19.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 1.95M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 3.20M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 1.35M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 5.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive | Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five | USD | 3.10M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 4.38M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-06 | 0001564590-20-021575 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five | USD | 4.38M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007841 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four | USD | 3.10M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007618 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three | USD | 3.10M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010603 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two | USD | 3.14M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-029951 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months | USD | 3.14M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-028374 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 576,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 4.27M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-06 | 0001564590-20-021575 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 685,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 665,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 646,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 266,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | Liabilities | Liabilities | USD | 225.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 230.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 89.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | LiabilitiesForGuaranteesOnLongDurationContractsBenefitsPaid | Liabilities for Guarantees on Long-Duration Contracts, Benefits Paid (Deprecated 2016-01-31) | USD | 944,000 | 2000-07-01 | 2007-06-30 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -18.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 141.98M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001193125-17-252860 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 5.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -42.51M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001193125-17-252860 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -4.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -82.61M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001193125-17-252860 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -18.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | 254,000 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-341301 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -17.66M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 25.00M | 2017-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | NotesPayableRelatedPartiesNoncurrent | Notes Payable, Related Parties, Noncurrent | USD | 50.00M | 2016-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-029951 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 96.30M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001193125-19-142333 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -8.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 3.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 5.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 359,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 5.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 3.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 5.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 17.84M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 3.19M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 2.97M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 2.88M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 2.80M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 2.72M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 3.27M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | OperatingLeasesRentExpense | Operating Lease, Rent Expense (Deprecated 2009-01-31) | USD | 580,000 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 967,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 52.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 4.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -55.30M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -11,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | OtherIncome | Other Income | USD | -599,000 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 4.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 677,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-06 | 0001193125-14-400994 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -10.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | OtherNonrecurringIncomeExpense | Other Nonrecurring (Income) Expense | USD | -240,000 | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-26 | 0001193125-12-132146 |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 344,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | OtherSundryLiabilitiesCurrent | Other Sundry Liabilities, Current | USD | 1.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-053964 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 2.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | PaymentsForProceedsFromInvestments | Payments for (Proceeds from) Investments | USD | -52.69M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001193125-17-252860 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 5.40M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010603 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 25.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 1.53M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 127.76M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001193125-19-142333 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 33.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 631,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 2.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 70,012 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 70,012 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 1.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | PrepaidExpenseAndOtherAssets | Prepaid Expense and Other Assets | USD | 14.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 7.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 11.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 1.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 31.86M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 1.30M | 2011-04-01 | 2011-04-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-451641 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 19.84M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 7.86M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 3.00M | 2012-05-01 | 2012-05-31 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-451641 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet | Proceeds from Issuance of Long-term Debt and Capital Securities, Net | USD | 194.30M | 2011-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-08 | 0001193125-15-179414 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 29.75M | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124698 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 225,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 883,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001564590-21-025796 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 363.13M | 2018-01-01 | 2018-06-30 | 2019 | Q2 | 10-Q | 2019-08-05 | 0001564590-19-028537 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 105.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 50.00M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | 24.35M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-028374 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 40.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 614,000 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-26 | 0001193125-12-132146 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 82,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 5.70M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0001564590-21-053953 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 4.93M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007618 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 1,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | ProductionRelatedImpairmentsOrCharges | Production Related Impairments or Charges | USD | 1.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -18.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 25.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 11.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 19.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | PurchaseObligationDueInNextTwelveMonths | Purchase Obligation, to be Paid, Year One | USD | 37.40M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-028374 | |
| us-gaap | PurchaseObligationDueInSecondAndThirdYear | Purchase Obligation, to be Paid, Year Two and Three | USD | 21.20M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-12 | 0000950170-24-029951 | |
| us-gaap | PurchaseObligationDueInSecondYear | Purchase Obligation, to be Paid, Year Two | USD | 11.80M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-028374 | |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 125.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 25.00M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 18.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 8.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | RestructuringAndRelatedCostExpectedCost1 | Restructuring and Related Cost, Expected Cost | USD | 9.40M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 | |
| us-gaap | RestructuringAndRelatedCostExpectedCostRemaining1 | Restructuring and Related Cost, Expected Cost Remaining | USD | 13.40M | 2023-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 5.40M | 2022-06-01 | 2022-06-30 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-028374 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 1.09M | 2017-12-31 | 2018 | FY | 10-K | 2019-02-22 | 0001193125-19-047780 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.96B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 107.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 5.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | SalesAllowancesGoods | Sales Allowances, Goods (Deprecated 2018-01-31) | USD | 342,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-23 | 0001193125-17-054088 |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 30.77M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 |
| us-gaap | SellingAndMarketingExpense | Selling and Marketing Expense | USD | 40.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 9.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate | Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date | pure | 0.85 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-451641 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-12 | 0001193125-14-194964 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.53 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-12 | 0001193125-14-194964 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.02 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-12 | 0001193125-14-194964 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 3.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | shares | 90.00M | 2011-06-01 | 2011-06-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001193125-13-437144 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 95.00M | 2011-06-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001193125-13-437144 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 8.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 200,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 11.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 4.64 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (Deprecated 2011-01-31) | shares | -37,786 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 167,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 528,773 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 1.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 6.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 1.02M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 7.52M | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-10 | 0001193125-13-213597 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 366,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 8.08 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 385,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-028374 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 28.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 2.84 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 10.61M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 28.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 2.98 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) | Y | 8.2 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased | Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased | USD/shares | 0.21 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-451641 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 27.81 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 20.91 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001564590-20-007973 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0.99 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | USD/shares | 4.64 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm1 | Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) | Y | 7.13 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | USD/shares | 5.2 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares | 11.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 28.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | USD/shares | 2.98 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1 | Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) | Y | 8.2 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | USD/shares | 38.46 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 |
| us-gaap | SharePrice | Share Price | USD/shares | 0.525 | 2012-07-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-451641 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 4.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 102.00M | 2012-07-01 | 2012-07-30 | 2012 | Q2 | 10-Q | 2012-08-09 | 0001193125-12-346661 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensationGross | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture | shares | 58,571 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-451641 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 7.88M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010603 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 225,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 162.15M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001564590-22-007618 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 57.80M | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091072 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures | USD | 98,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 98,000 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | -68,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 6.76M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007841 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 10.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001193125-14-087658 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-073515 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 200,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010603 |
| us-gaap | UnrecognizedTaxBenefitsResultingInNetOperatingLossCarryforward | Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforward (Deprecated 2014-01-31) | USD | 13.90M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 100,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 | |
| us-gaap | UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount | Unrecorded Unconditional Purchase Obligation | USD | 35.90M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-27 | 0001193125-18-060951 | |
| us-gaap | ValuationAllowanceAmount | Valuation Allowance, Amount (Deprecated 2013-01-31) | USD | -19.20M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 55.20M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-23 | 0001193125-17-054088 |
| us-gaap | ValuationAllowancesAndReservesBalance | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount | USD | 47.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 | |
| us-gaap | ValuationAllowancesAndReservesDeductions | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction | USD | 198.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | ValuationAllowancesAndReservesPeriodIncreaseDecrease | SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) | USD | 8.90M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-01 | 0001193125-13-085823 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 190.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 102.12M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0001564590-22-018877 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 190.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452759 |